Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CHC Healthcare GroupTPE:4164 +0.97%79 EV-to-OCF is 17.51 as of Sep. 21, 2026, which is 10% above its 10-year median of 15.89. GuruFocus rates TPE:4164 with a GF Score™ of 79/100 and a GF Value™ of NT$49.11 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 122 Medical Distribution companies, CHC Healthcare Group ranks worse than 84.43% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, CHC Healthcare Group's Enterprise Value is NT$9,706 Mil.
CHC Healthcare Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was NT$554 Mil. Therefore, CHC Healthcare Group's EV-to-OCF for today is 17.51.
The historical rank and industry rank for CHC Healthcare Group's EV-to-OCF or its related term are showing as below:
TPE:4164'
s EV-to-OCF Range Over the Past 10 Years
Min: 5 Med: 15.89 Max: 158.09
Current: 21.55
During the past 13 years, the highest EV-to-OCF of CHC Healthcare Group was 158.09. The lowest was 5.00. And the median was 15.89.
TPE:4164's EV-to-OCF is ranked worse than 84.43% of 122
companies
in the Medical Distribution industry
Industry Median: 7.59
vs TPE:4164: 21.55
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CHC Healthcare Group (TPE:4164) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
CHC Healthcare Group's PE Ratio (TTM) for today is calculated as:
CHC Healthcare Group's share price for today is NT$26.05.
CHC Healthcare Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1.145.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
CHC Healthcare Group EV-to-OCF Related Terms
CHC Healthcare Group EV-to-OCF Historical Data
* Premium members only.
The historical data trend for CHC Healthcare Group's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, CHC Healthcare Group's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CHC Healthcare Group EV-to-OCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, CHC Healthcare Group's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where CHC Healthcare Group's EV-to-OCF falls into.
CHC Healthcare Group's current Enterprise Value is NT$9,706 Mil.
CHC Healthcare Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$554 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHC Healthcare Group (TPE:4164) has a EV-to-OCF of 17.51 as of Sep. 21, 2026. This is 10% above median its historical median of 15.89. Over the past decade, CHC Healthcare Group's EV-to-OCF has ranged from 5.00 to 158.09. According to the industry distribution chart, CHC Healthcare Group ranks #103 out of 122 companies in the Medical Distribution industry, placing it in the top 84.4%.
Is CHC Healthcare Group's EV-to-OCF too high?
CHC Healthcare Group's current EV-to-OCF of 17.51 is 10% above median its 10-year median of 15.89. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 158.09. The Medical Distribution industry median EV-to-OCF is 7.59. CHC Healthcare Group's value of 17.51 is 130.7% above this industry median. Based on the distribution chart, CHC Healthcare Group ranks #103 out of 122 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, CHC Healthcare Group has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CHC Healthcare Group's EV-to-OCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, CHC Healthcare Group ranks #103 out of 122 companies for EV-to-OCF. This places CHC Healthcare Group in the lower half of its industry. The industry median EV-to-OCF is 7.59. CHC Healthcare Group's value of 17.51 is 130.7% above this benchmark. Historically, CHC Healthcare Group's own EV-to-OCF has ranged from 5.00 to 158.09 over the past decade. While the company's 10-year median is 15.89 vs. the industry median of 7.59, CHC Healthcare Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Distribution company?
The median EV-to-OCF among Medical Distribution companies is 7.59, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CHC Healthcare Group's current EV-to-OCF of 17.51 is 130.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median EV-to-OCF is 7.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CHC Healthcare Group's current EV-to-OCF is 17.51, which is 10% above median its own 10-year median of 15.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CHC Healthcare Group stock overvalued right now?
Based on GuruFocus' analysis, CHC Healthcare Group (TPE:4164) is currently considered Possible Value Trap. The stock's GF Value™ is NT$49.11, compared to a current price of NT$26.05 — trading 47% below its estimated fair value. The current EV-to-OCF is 17.51, which is 10% above median its 10-year median of 15.89 and 130.7% above the Medical Distribution industry median of 7.59. CHC Healthcare Group's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For CHC Healthcare Group (TPE:4164), the current EV-to-OCF is 17.51 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CHC Healthcare Group (TPE:4164) Overvalued in 2026?
Based on GuruFocus' analysis, CHC Healthcare Group stock appears to be undervalued.
The current stock price of NT$26.05 is trading 47% below its estimated GF Value™ of NT$49.11.
GuruFocus considers CHC Healthcare Group to be Possible Value Trap.
Key valuation signals for TPE:4164:
EV-to-OCF: 17.51 (10% above median its 10-year median of 15.89)
GF Value™: NT$49.11 vs. price of NT$26.05 (47% below fair value)
Industry Position: 130.7% above the Medical Distribution median (#103 of 122)
No single metric tells the full story. See the TPE:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CHC Healthcare Group is a Taiwan-based company engaged in the trading of pharmaceutical products and health food, as well as the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment used in radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, the sale of medical instruments, repairs, maintenance, and other services.
79GF Score
Get the complete analysis for TPE:4164
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4164 has been successfully added to your 
